Advanced search
Publication Cover
Acta Orthopaedica Volume 87, 2016 - Issue 3
Journal homepage
1,239
Views
6
CrossRef citations to date
0
Altmetric
Correspondence

Which is the best treatment for prosthetic joint infections due to Propionibacterium acnes: need for further biofilm in vitro and experimental foreign-body in vivo studies?

Stéphane CorvecService de Bactériologie-Hygiène hospitalière, CHU de Nantes, and EA3826 Thérapeutiques cliniques et expérimentales des infections, Faculté de Médecine, Nantes, FranceCorrespondence[email protected]
,
Guillaume G AubinService de Bactériologie-Hygiène hospitalière, CHU de Nantes, and EA3826 Thérapeutiques cliniques et expérimentales des infections, Faculté de Médecine, Nantes, FranceCorrespondence[email protected]
,
Roger BaystonBRIG, Academic Orthopaedics, University Hospitals Queen’s Medical Centre, Nottingham, UKCorrespondence[email protected]
&
Waheed AshrafBRIG, Academic Orthopaedics, University Hospitals Queen’s Medical Centre, Nottingham, UKCorrespondence[email protected]
Pages 318-319 | Published online: 04 Apr 2016

  • Aubin G G, Portillo M E, Trampuz A, Corvec S. Propionibacterium acnes, an emerging pathogen: from acne to implant-infections, from phylotype to resistance. Médecine Mal Infect 2014; 44(6): 241–50.
  • Bayston R, Nuradeen B, Ashraf W, Freeman B J C. Antibiotics for the eradication of Propionibacterium acnes biofilms in surgical infection. J Antimicrob Chemother 2007; 60(6): 1298–301.
  • Bayston R, Ashraf W. Treatment of prosthetic joint infections due to Propionibacterium. Acta Orthop 2016; 87(1): 60–6.
  • Crane J K, Hohman D W, Nodzo S R, Duquin T R. Antimicrobial susceptibility of Propionibacterium acnes isolates from shoulder surgery. Antimicrob Agents Chemother 2013; 57(7): 3424–6.
  • Furustrand Tafin U, Corvec S, Betrisey B, Zimmerli W, Trampuz A. Role of rifampin against Propionibacterium acnes biofilm in vitro and in an experimental foreign-body infection model. Antimicrob Agents Chemother 2012; 56(4): 1885–91.
  • Furustrand Tafin U, Trampuz A, Corvec S. In vitro emergence of rifampicin resistance in Propionibacterium acnes and molecular characterization of mutations in the rpoB gene. J Antimicrob Chemother 2013; 68(3): 523–8.
  • Furustrand Tafin U, Aubin G G, Eich G, Trampuz A, Corvec S. Occurrence and new mutations involved in rifampicin-resistant Propionibacterium acnes strains isolated from biofilm or device- related infections. Anaerobe 2015; 34: 116–9.
  • Jacobs A M E, Van Hooff M L, Meis J F, Vos F, Goosen J H M. Treatment of prosthetic joint infections due to Propionibacterium. Acta Orthop. 2015 Sep 28;1–7.
  • Khassebaf J, Hellmark B, Davidsson S, Unemo M, Nilsdotter-Augustinsson Å, Söderquist B. Antibiotic susceptibility of Propionibacterium acnes isolated from orthopaedic implant-associated infections. Anaerobe 2015; 32: 57–62.
  • Portillo M E, Corvec S, Borens O, Trampuz A. Propionibacterium acnes: an underestimated pathogen in implant-associated infections. BioMed Res Int 2013; 2013: 804391.
  • Ross J I, Snelling AM, Eady E A, Cove J H, Cunliffe W J, Leyden J J, et al. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br J Dermatol 2001; 144(2): 339–46.
  • Shah N B, Tande A J, Patel R, Berbari EF . Anaerobic prosthetic joint infection. Anaerobe 2015; 36: 1–8.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.